SECURITY AGREEMENTSecurity Agreement • January 21st, 2021 • 1315 Capital II, L.P. • Surgical & medical instruments & apparatus • Delaware
This SECURITY AGREEMENT, dated as of January 7, 2021 (as amended, supplemented or otherwise modified from time to time in accordance with the provisions hereof, this “Agreement”), is made by INTERPACE BIOSCIENCES, INC., a Delaware corporation (the “Grantor”), in favor of Ampersand 2018 Limited Partnership, a Delaware limited partnership, in its capacity as collateral agent pursuant to the Notes (as hereinafter defined), as secured party (in such capacity, the “Secured Party”).
AMENDMENT TO SECURED PROMISSORY NOTESecured Promissory Note • May 20th, 2021 • 1315 Capital II, L.P. • Surgical & medical instruments & apparatus
This Amendment to Secured Promissory Note (this “Amendment”) is made and entered into as of May 10, 2021 (the “Amendment Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Borrower”), and 1315 Capital II, L.P., a Delaware limited partnership (the “Noteholder”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Note (as defined below).
SUPPORT AGREEMENTSupport Agreement • April 30th, 2020 • 1315 Capital II, L.P. • Surgical & medical instruments & apparatus • Delaware
THIS SUPPORT AGREEMENT (this “Agreement”) is entered into as of April 2, 2020, by and between 1315 Capital II, L.P., a Delaware limited partnership (“1315 Capital”), and Interpace Biosciences, Inc., a Delaware corporation (the “Company”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 24th, 2021 • 1315 Capital II, L.P. • Services-misc health & allied services, nec • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (this “Agreement”), is made as of the 17th day of May, 2019, by and among Greenbrook TMS Inc., an Ontario corporation (the “Company”), and 1315 Capital II, LP, a Delaware limited partnership (“Investor” or a “Holder”).
AMENDMENT TO SECURITY AGREEMENTSecurity Agreement • May 20th, 2021 • 1315 Capital II, L.P. • Surgical & medical instruments & apparatus
This Amendment to Security Agreement (this “Amendment”) is made and entered into as of May 10, 2021 (the “Effective Date”) by and between Interpace Biosciences, Inc., a Delaware corporation (the “Grantor”), and Ampersand 2018 Limited Partnership, a Delaware limited partnership in its capacity as collateral agent pursuant to the Notes (as hereinafter defined), as secured party (in such capacity, the “Secured Party”). Capitalized terms used herein but not otherwise defined shall have the respective meanings given to them in the Notes.
SUBSCRIPTION AGREEMENT FOR COMMON SHARESSubscription Agreement for Common Shares • June 24th, 2021 • 1315 Capital II, L.P. • Services-misc health & allied services, nec • Ontario
The undersigned (referred to herein as the “Purchaser”) hereby irrevocably undertakes to the Corporation to subscribe for and agrees to purchase from the Corporation, and the Corporation agrees to allot and issue, that number of common shares of the Corporation (the “Subscribed for Shares” and each individually, a “Subscribed for Share”) equal to the aggregate subscription price set forth below (the “Aggregate Subscription Price”), representing a subscription price of C$3.25 per Subscribed for Share (the “Subscription Price”), upon and subject to the attached terms and conditions (the “Terms and Conditions”). This subscription, the attached Terms and Conditions and any schedules or appendices attached hereto and thereto are collectively referred to as the “Subscription Agreement”. The Purchaser agrees to be bound by the Terms and Conditions and agrees that the Corporation and the Underwriters and the U.S. Affiliates may rely upon the covenants, representations and warranties contained
